semaglutide .025 0.25mg/0.5ml .25mg behavior change The UK's MRHA has approved – Losing weight and keeping it off can lessen the many health risks that come with obesity Medscape | The FDA has

The molecule was rationally designed by Eli Lilly scientists to simultaneously engage three G-protein-coupled receptors central to metabolic homeostasis: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor

This promotes better blood sugar control

This dual-pathway activation produces superior weight loss and metabolic improvements in randomized trials, with some non-responders to GLP-1 monotherapy achieving meaningful results after switching to tirzepatide

Semaglutide works by mimicking a natural hormone that tells your brain youre full, which can help you eat less